Join to View Full Profile
6 Devine StreetYale New Haven Health North Haven Medical CenterNorth Haven, CT 06473
Dr. Bar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2009 - 2012
Tel Aviv University SacklerClass of 2009
Certifications & Licensure
CT State Medical License 2016 - 2027
NY State Medical License 2011 - 2014
CO State Medical License 2012 - 2013
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2017
Publications & Presentations
PubMed
- Alnuctamab, a bivalent B-cell maturation antigen-targeting T cell engager for patients with relapsed or refractory multiple myeloma: results from a phase 1, first-in-h...Noffar Bar, Thomas Martin, Craig C Hofmeister, Maria-Victoria Mateos, Markus Hansson
Leukemia. 2026-03-01 - Ciltacabtagene Autoleucel Versus Idecabtagene Vicleucel in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma with 2-4 Prior Lines of Therapy: Updated Matching-...Nieves Lopez-Muñoz, Noffar Bar, Joris Diels, Suzy van Sanden, João Mendes
Advances in Therapy. 2026-03-01 - Once weekly bortezomib decreases rates of peripheral neuropathy without diminishing efficacy as compared to twice weekly bortezomib in combination with lenalidomide, d...Eleni Gaspar, Irvin Yi, Noffar Bar
Leukemia & Lymphoma. 2025-07-01
Abstracts/Posters
- Peripheral Blood Involvement By Flow Cytometry As a Prognostic Factor in Aggressive T Cell Lymphomas Following Autologous Stem Cell TransplantationNoffar Bar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Immune Checkpoint Inhibitor Therapy for Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes: A Single-Center ExperienceNoffar Bar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
